Subscribe to our Rss Follow us on Twitter! Follow us on TLinkedin!

Archive for 'Tag Archives: 'UCL''

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.

Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

iTeos Therapeutics (Gosselies, Belgium), kicks-off to develop innovative immunotherapy compounds in an effort to cure certain cancers.

The birth of a Belgian company, a joint spin-off of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute of the Université catholique de Louvain (UCL), focusing on new drug discovery, has been made [...]

Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.

Promethera Biosciences of Belgium attracts international investors allowing promising future for treatment of liver disease.

UCL spin off biotechnology company Promethera Biosciences (Mont-Saint Guibert, Wallonia/Belgium), with the help and support of pharmaceutical groups and investors worldwide, is targeting a medical breakthrough with an innovative therapeutic cell product designed to treat liver [...]

Belgian biotech company, Delphi Genetics SA, launches new research project to develop antibiotic-free DNA vaccines

Belgian biotech company, Delphi Genetics SA, launches new research project to develop antibiotic-free DNA vaccines

Using the Staby® technology, the DNAVAC research project aims to develop and produce antibiotic-free DNA vaccines that will target certain veterinary diseases. Over the next three years, Delphi Genetics will work seamlessly and in close collaboration [...]